Dr. Schmitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St NE
Fl 11
Atlanta, GA 30308Phone+1 404-778-1900Fax+1 404-778-1251
Education & Training
- University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2006 - 2013
- University of WashingtonResidency, Surgery, 2006 - 2008
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- GA State Medical License 2019 - 2025
- MD State Medical License 2015 - 2021
- PA State Medical License 2013 - 2016
- WA State Medical License 2006 - 2013
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Clinical Trials
- Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer Start of enrollment: 2022 Feb 17
Roles: Contact, Principal Investigator
- Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer Start of enrollment: 2024 Jun 26
Roles: Contact
Publications & Presentations
PubMed
- Radiologic findings of occult nodal metastasis during clinically-N0 salvage total laryngectomy.Tyler G Chan, Jaime Wicks, Ila Sethi, Jennifer Becker, David Brandon
Head & Neck. 2025-01-01 - Age and postoperative swallowing function in patients treated for advanced oral cancer: A retrospective study.Seth E Amos, Georges E Daoud, Shubham R Patel, Andre J Burnham, Lauren Ottenstein
Journal of Geriatric Oncology. 2024-11-01 - Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.Nabil F Saba, Ritu Chaudhary, Kedar Kirtane, Angelo Marra, Asari Ekpenyong
Clinical Cancer Research. 2024-10-15
Journal Articles
- Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct CarcinomasLisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
- Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell CarcinomaNicole C Schmitt, Clint T Allen, Clinical Cancer Research
Press Mentions
- WashU ENT Has Strong Presence at Annual AAO-HNSF MeetingAugust 30th, 2022
- Subtype-Specific Responses of hKv7.4 and hKv7.5 Channels to Polyunsaturated Fatty Acids Reveal an Unconventional Modulatory Site and MechanismJune 1st, 2022
- Research Roundup: Recent Grants and Publications for Emory Faculty and StaffSeptember 21st, 2021
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: